ch.oddb.org
 
Apotheken | Arzt | Interaktionen | Medikamente | MiGeL | Services | Spital | Zulassungsi.
Fachinformation zu Zantic®:GlaxoSmithKline AG
Vollst. FachinformationDDDDrucken 
Gal.Form/Ther.Gr.Zusammens.Eigensch.Pharm.kinetikInd./Anw.mögl.Dos./Anw.Anw.einschr.Unerw.Wirkungen
Interakt.Überdos.Sonstige H.Swissmedic-Nr.Stand d. Info. 
A02BA02 - RanitidineATC-DDD Version 2016. Source: WHO
A - Alimentary Tract and Metabolism
 
A02 - Drugs for Acid Related Disorders
 
A02B - Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord)
 
A02BA - H2-Receptor Antagonists

Ranitidine bismuth citrate is classified here, whereas other bismuth salts are classified in A02BX.

The DDDs are based on treatment of peptic ulcers.

A02BA02 - Ranitidine
StärkeAdm.RouteNote
 O 
 P 
2025 ©ywesee GmbH
Einstellungen | Hilfe | FAQ | Anmeldung | Kontakt | Home